Authors: Zane, C Leali, C Airo, P De Panfilis, G Pinton, PC

Citation: C. Zane et al., "High-dose" UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides, J AM ACAD D, 44(4), 2001, pp. 629-633

Authors: Calzavara-Pinton, PG Zane, C Candiago, E Facchetti, F

Citation: Pg. Calzavara-pinton et al., Blisters on psoriatic lesions treated with TL-01 lamps, DERMATOLOGY, 200(2), 2000, pp. 115-119

Authors: Parodi, A Caproni, M Cardinali, C Bernacchi, E Fuligni, A De Panfilis, G Zane, C Papini, M Veller, FC Vaccaro, M Fabbri, P

Citation: A. Parodi et al., Clinical, histological and immunopathological features of 58 patients withsubacute cutaneous lupus erythematosus - A review by the Italian Group of Immunodermatology, DERMATOLOGY, 200(1), 2000, pp. 6-10

Authors: Franceschini, F Calzavara-Pinton, P Quinzanini, M Cavazzana, I Bettoni, L Zane, C Facchetti, F Airo, P McCauliffe, DP Cattaneo, R

Citation: F. Franceschini et al., Chilblain lupus erythematosus is associated with antibodies to SSA Ro, LUPUS, 8(3), 1999, pp. 215-219

Authors: Calzavara-Pinton, PG Franceschini, F Manera, C Zane, C Prati, E Cretti, L Braga, S Cattaneo, R

Citation: Pg. Calzavara-pinton et al., Antiperinuclear factor in psoriatic arthropathy, J AM ACAD D, 40(6), 1999, pp. 910-913